Photochemical Fluorination of Aryl Halides

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for introducing fluorine into pharmaceutical and agrochemical structures often require harsh reaction conditions, toxic reagents, or transition metal catalysts, making them unsuitable for late-stage modification of biologically active compounds.

Innovation Solution

A light-mediated nucleophilic aromatic substitution reaction using an aryl halide, a fluorinated alcohol, a photocatalyst, and irradiation with electromagnetic radiation between 200 nm and 800 nm, which allows for the introduction of fluorinated functional groups under mild conditions, such as room temperature and with a metal-free photocatalyst.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional fluorination methods are used, then fluorine can be introduced into pharmaceutical and agrochemical structures, but harsh reaction conditions, toxic reagents, or transition metal catalysts are required

Engineering Contradiction:
Improvefluorine introduction effectivenessVSAvoidharsh conditions and toxic reagents
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces conventional thermal or catalytic fluorination methods with a photchemical approach using visible light irradiation. The photocatalyst absorbs light energy to generate excited states that facilitate fluorine transfer from fluorinated reagents to aromatic substrates, eliminating the need for harsh temperatures or toxic catalysts while maintaining effective fluorine introduction

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the reaction conditions by using visible light (400-800 nm) instead of thermal energy or chemical catalysts. This parameter change allows the reaction to proceed at mild temperatures with simple bases like sodium bicarbonate, avoiding harsh conditions while achieving effective fluorination

Inventive Principle:
Principle #35Parameter changes

2Reliability

If existing fluorination methods are used, then fluorinated compounds can be synthesized, but the methods are unsuitable for late-stage modification of biologically active compounds

Engineering Contradiction:
Improvefluorine incorporation capabilityVSAvoidsuitability for late-stage modification
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent employs photocatalysis with visible light to enable late-stage fluorination of biologically active compounds. The mild reaction conditions (room temperature, simple base, no toxic reagents) allow modification of complex molecules without compromising their biological activity, making the method ideal for late-stage optimization

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent uses a photocatalyst as an intermediary that mediates the fluorine transfer process. The photocatalyst absorbs light energy and generates reactive species that facilitate fluorine incorporation under mild conditions, enabling selective modification of biologically active compounds without requiring harsh conditions

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If conventional fluorination methods are used, then fluorinated compounds can be prepared, but expensive reagents and transition metal catalysts are required

Engineering Contradiction:
Improvefluorine introduction efficiencyVSAvoidcost and complexity of reagents
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent employs inexpensive, easily available fluorinated reagents and simple bases like sodium bicarbonate as the only additives. The photocatalyst can be used in catalytic amounts and is replaceable with inexpensive organic dyes or compounds. This eliminates the need for expensive reagents and valuable transition metal catalysts, making the method economically viable

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent replaces expensive transition metal catalysts with organic photocatalysts that can be activated by visible light. This substitution reduces material costs and simplifies the overall process, as the photocatalyst system uses only light energy and inexpensive chemical components to drive the fluorination reaction

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method enables the efficient and selective introduction of fluorine into biologically active compounds, providing access to new fluorinated derivatives with potentially desirable properties, such as enhanced metabolic stability and biological activity, while avoiding the use of harsh conditions and toxic reagents.

Implementation Method 1

irradiation with electromagnetic radiation comprising a wavelength between about 200 nm and about 800 nm

Methodology Applied
Scientific EffectPhotochemical activation: Photopolymerisation

Data Source

PatentUS20240300878A1Photochemical preparation of fluorine-containing compounds
Publication Date: 2024.09.12 WISYS TECHNOLOGY FOUNDATION INC
  • US20240300878A1 patent drawing
  • US20240300878A1 patent drawing
  • US20240300878A1 patent drawing

AI summary

Various embodiments disclosed relate to a method of preparing aryl fluorinated ether compounds. The method involves contacting an aryl halide with a fluorinated alcohol in the presence of a photocatalyst, a base, and irradiation with electromagnetic radiation comprising a wavelength between about 200 nm and about 800 nm. The present invention also provides a method of late-stage photochemical modification of a biologically active compound, such as drugs or agrochemicals. Fluorinated derivatives of griseofulvin, clofibrate, and 2,4-D methyl ester are described herein.